Carcinoid Tumor Clinical Trials Carcinoid Tumor RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl
Conditions:   Neuroendocrine Tumors;   Carcinoid Syndrome;   Diarrhea Interventions:   Drug: Telotristat ethyl;   Drug: Peptide Receptor Radionuclide Therapy;   Other: Placebo Sponsors:   Big Ten Cancer Research Consortium;   TerSera Therapeutics LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2021 Category: Research Source Type: clinical trials

Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors
Condition:   Neuroendocrine Tumors Intervention:   Drug: Telotristat Ethyl Oral Tablet Sponsor:   University of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2020 Category: Research Source Type: clinical trials

Cabozantinib and Nivolumab for Carcinoid Tumors
Conditions:   Carcinoid Tumor;   Carcinoid Tumor of GI System;   Neuroendocrine Tumors Interventions:   Drug: Nivolumab;   Drug: Cabozantinib Sponsors:   Dana-Farber Cancer Institute;   Bristol-Myers Squibb;   Exelixis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2019 Category: Research Source Type: clinical trials